How can we help?

Communicate the value proposition of your product in payer-accessible language, using payer-relevant evidence and informed market access trade-offs and strategy.

Payer-relevant evidence

Generate payer-relevant evidence to communicate the value proposition of your product in payer-relevant terms, and gain insights into the interdependency between pricing, reimbursement, and HTA.

Generate payer-relevant evidence to communicate the value proposition of your product in payer-relevant terms, and gain insights into the interdependency between pricing, reimbursement, and HTA.

Informed business decisions

From as early as the pre-clinical stage we can work with you to inform key business decisions relating to pricing, access, and evidence, which can be refined as your product moves through clinical development.

From as early as the pre-clinical stage we can work with you to inform key business decisions relating to pricing, access, and evidence, which can be refined as your product moves through clinical development.

Supporting your submissions

Support HTA and reimbursement submissions with well planned and executed evidence generation activities that inform trial design and model development, and help to define unmet needs.

Support HTA and reimbursement submissions with well planned and executed evidence generation activities that inform trial design and model development, and help to define unmet needs.

Understanding your challenges

We understand your business challenges and provide partnership to enable informed market access trade-offs and strategy.

We understand your business challenges and provide partnership to enable informed market access trade-offs and strategy.

Test value strategies

Test and refine value strategies through advisory boards and expert panels with our network of over 2,000 advisors.

Test and refine value strategies through advisory boards and expert panels with our network of over 2,000 advisors.

Payer-accessible communication

Approach value communication, whether at the global, regional, or local level, using consistent evidence-based messages in payer-accessible language.

Approach value communication, whether at the global, regional, or local level, using consistent evidence-based messages in payer-accessible language.

As we implement our strategy in Asia, your considerable help, insight, and agility has been invaluable in informing our executive discussions.

Senior Director, Global Value & Access, top-20 pharmaceutical company

Case studies

Find out how we partner with clients to enable faster patient access to therapies that improve health outcomes.

You have a vision; we are the consulting partner that will get you there.

We would be delighted to have a confidential conversation about your market access needs.